Shanghai Sanyou Medical Co., Ltd (SHA:688085)
13.07
+0.17 (1.32%)
Nov 13, 2026, 3:00 PM CST
Shanghai Sanyou Medical Revenue
Shanghai Sanyou Medical had revenue of 166.12M CNY in the quarter ending September 30, 2026, with 17.23% growth. This brings the company's total for the last twelve months to 591.46M, up 15.45% year-over-year. In the year 2025, Shanghai Sanyou Medical had annual revenue of 542.79M with 19.66% growth. That makes Shanghai Sanyou Medical the 23,625th largest company in the world by revenue and 4,264th in China.
Revenue (ttm)
591.46M
Revenue Growth
+15.45%
P/S Ratio
7.98
Revenue / Employee
1.10M
Employees
562
Market Cap
4.72B
Revenue by Segment
Fiscal year ended Dec 31, 2025 See the full Shanghai Sanyou Medical breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 542.79M | 89.20M | 19.66% |
| Dec 31, 2024 | 453.60M | -6.80M | -1.48% |
| Dec 31, 2023 | 460.39M | -188.76M | -29.08% |
| Dec 31, 2022 | 649.15M | 55.79M | 9.40% |
| Dec 31, 2021 | 593.36M | 202.93M | 51.97% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Wuhan Huakang Century Clean Technology | 2.63B |
| Maccura Biotechnology Co.Ltd | 2.18B |
| BMC Medical | 1.44B |
| Shenzhen Lifotronic Technology | 1.20B |
| Getein Biotech | 1.11B |
| SWS Hemodialysis Care | 959.44M |
| Shanghai Kinetic Medical | 734.04M |
| Ningbo Jansen Superconducting Technologies | 719.90M |